DMRA Insider Trading Activity and SEC Form 4 Filings
DMRA insider trading summary
Over the past 12 months, insiders at Damora Therapeutics, Inc. (DMRA) reported 1 open-market purchase worth $253K by 1 insider and 1 sale worth $7K by 1 insider on SEC Form 4. Net insider buying was $246K.
Latest DMRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Jennifer Jarrett | Director, President and CEO | Buy | $253K (12,500 @ $20.23) |
| Jul 6, 2026 | Garrett Winslow | General Counsel | Sell | $7K (245 @ $29.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.